Company / AR per Share
Avalo Therapeutics, Inc. AR per Share History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
-
FY2022
5-year range
$0.00 / $0.01
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.05 to $0.00 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, ar per share decreased 100.0% year-over-year.
- Peak ar per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.01 | -71.2% |
| FY2020 | $0.05 | +99.8% |
| FY2019 | $0.02 | -6.7% |
| FY2018 | $0.03 | -91.5% |
| FY2017 | $0.31 | - |
As of FY2022 · SEC Form 10-K · Last checked Jun 21, 2026